Literature DB >> 23698209

Squamous cell carcinoma of skin: a brief review.

S Rahimi1.   

Abstract

Cutaneous squamous cell carcinoma (SCC) is the second most common skin cancer in Caucasians, most frequently occurring on sun-exposed areas of the body. Most SCCs are treated surgically, either by excision or Mohs micrographic surgery. Despite the large amount of English literature with regard to cutaneous SCC in many instances the surgical treatment is not appropriate resulting in recurrences and/ or metastasis. The following brief review highlights the histology, molecular biology and surgical treatment of skin SCC.

Entities:  

Mesh:

Year:  2013        PMID: 23698209     DOI: 10.7417/CT.2013.1534

Source DB:  PubMed          Journal:  Clin Ter        ISSN: 0009-9074


  6 in total

1.  Lgr5-positive cells are cancer stem cells in skin squamous cell carcinoma.

Authors:  Shunli Liu; Zhenyu Gong; Mingrui Chen; Benli Liu; Donghui Bian; Kai Wu
Journal:  Tumour Biol       Date:  2014-08-19

2.  Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma.

Authors:  Li Zhang; Ping Xiang; Xuan Han; Liyong Wu; Xuwen Li; Zhuyou Xiong
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  TIPE2 regulates tumor-associated macrophages in skin squamous cell carcinoma.

Authors:  Xin Li
Journal:  Tumour Biol       Date:  2015-11-15

4.  MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.

Authors:  Jianda Zhou; Rui Liu; Chengqun Luo; Xiao Zhou; Kun Xia; Xiang Chen; Ming Zhou; Qiong Zou; Peiguo Cao; Ke Cao
Journal:  Cancer Biol Ther       Date:  2014-07-14       Impact factor: 4.742

Review 5.  The role of EphA7 in different tumors.

Authors:  Xiangyi Chen; Dechen Yu; Haiyu Zhou; Xiaobo Zhang; Yicun Hu; Ruihao Zhang; Xidan Gao; Maoqiang Lin; Taowen Guo; Kun Zhang
Journal:  Clin Transl Oncol       Date:  2022-02-02       Impact factor: 3.405

6.  Aberrant DNA Methylation in Keratoacanthoma.

Authors:  Yoshimasa Nobeyama; Hidemi Nakagawa
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.